MedPath

Comparison of imaging pattern and diagnostic value of F-18 FLT and F-18 FDG PET in patients with rectal cancer before and after neoadjuvant radiochemotherapy

Conditions
anorectal cancer
Registration Number
EUCTR2006-003828-11-AT
Lead Sponsor
Prim. Univ.Prof. Dr. Christian Pirich Department of Nuclear Medicine and Endocrinology, PMU Salzburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Included in this study will be between 18 and 80 years old male and female patients with proven rectal tumour (by biopsy and histology).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Excluded from this study are patients that are not able to lie motionless without pain for one hour, pregnant women and breast-feading women.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: The comparison of F-18 FLT and F-18 FDG tumour uptake before and after neoadjuvant radiochemotherapy (related to clinical, radiological and PET-CT criteria of response) and the evaluation of the tumour response to therapy. ;Secondary Objective: The relation and comparison of the F-18 FLT and F-18 FDG uptake pattern of rectal tumours to the molecular tumour pattern and the determination of differences of F-18 FLT and F-18 FDG uptake (degree of tumour proliferation, glycolysis and histological signs of concomitant inflammation).;Primary end point(s): ?
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath